Insider · CIK 0001733790
Joseph J Ferra Jr
ceoofficerdirector
Files at ELEV (Elevation Oncology, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | ELEV Elevation Oncology, Inc. | MOption exercise Common Stock | +12,560 | - | - | 149,712 | Jun 18, 2025 |
| Jun 16, 2025 | ELEV Elevation Oncology, Inc. | FTax withholding Common Stock | -4,627 | $0.39 | $1,783 | 145,085 | Jun 18, 2025 |
| Jun 16, 2025 | ELEV Elevation Oncology, Inc. | MOption exercise Restricted Stock Unitderivative | -12,560 | $0.00 | $0 | 0 | Jun 18, 2025 |
| May 15, 2025 | ELEV Elevation Oncology, Inc. | MOption exercise Common Stock | +6,250 | - | - | 139,455 | May 19, 2025 |
| May 15, 2025 | ELEV Elevation Oncology, Inc. | FTax withholding Common Stock | -2,303 | $0.30 | $690 | 137,152 | May 19, 2025 |
| May 15, 2025 | ELEV Elevation Oncology, Inc. | MOption exercise Restricted Stock Unitderivative | -6,250 | $0.00 | $0 | 68,750 | May 19, 2025 |
| Mar 16, 2025 | ELEV Elevation Oncology, Inc. | MOption exercise Common Stock | +12,562 | - | - | 137,833 | Mar 18, 2025 |
| Mar 16, 2025 | ELEV Elevation Oncology, Inc. | FTax withholding Common Stock | -4,628 | $0.53 | $2,466 | 133,205 | Mar 18, 2025 |
| Mar 16, 2025 | ELEV Elevation Oncology, Inc. | MOption exercise Restricted Stock Unitderivative | -12,562 | $0.00 | $0 | 12,560 | Mar 18, 2025 |
| Feb 15, 2025 | ELEV Elevation Oncology, Inc. | MOption exercise Common Stock | +25,000 | - | - | 134,482 | Feb 19, 2025 |
| Feb 15, 2025 | ELEV Elevation Oncology, Inc. | FTax withholding Common Stock | -9,211 | $0.67 | $6,187 | 125,271 | Feb 19, 2025 |
| Feb 15, 2025 | ELEV Elevation Oncology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +800,000 | $0.00 | $0 | 800,000 | Feb 19, 2025 |
| Feb 15, 2025 | ELEV Elevation Oncology, Inc. | MOption exercise Restricted Stock Unitderivative | -25,000 | $0.00 | $0 | 75,000 | Feb 19, 2025 |
| Dec 16, 2024 | ELEV Elevation Oncology, Inc. | MOption exercise Common Stock | +12,563 | - | - | 114,111 | Dec 18, 2024 |
| Dec 16, 2024 | ELEV Elevation Oncology, Inc. | FTax withholding Common Stock | -4,629 | $0.64 | $2,963 | 109,482 | Dec 18, 2024 |
| Dec 16, 2024 | ELEV Elevation Oncology, Inc. | MOption exercise Restricted Stock Unitderivative | -12,563 | $0.00 | $0 | 25,122 | Dec 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.